Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations. Nwabufo CK. Cancer Chemother Pharmacol 2023 Aug 18. doi: 10.1007/s00280-023-04575.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nwabufo CK. Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations. Cancer Chemother Pharmacol 2023 Aug 18. doi: 10.1007/s00280-023-04575.
PMID: 37594572